MCM
BHVN icon

Moore Capital Management’s Biohaven BHVN Stock Holding History

Moore Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-37,700
Closed -$981K – 451
2023
Q3 		$981K Hold
37,700
– – 0.02% 305
2023
Q2 		$902K Buy
+37,700
New +$649K 0.02% 316

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Moore Capital Management's BHVN Position: Q1 2024 in Review

Moore Capital Management sold out of Biohaven (BHVN) in Q1 2024, closing a stake of 22,700 shares — an estimated $972K sold.

Moore Capital Management first reported a position in BHVN in Q2 2023 and held it in 2 quarters. The position peaked at $2.39M in Q2 2023. 243 funds tracked by Wall St. Rank hold BHVN as of Q1 2024.

  • Moore Capital Management reported no remaining Biohaven position as of Q1 2024 after selling out during the quarter.
  • Moore Capital Management sold 22,700 Biohaven shares in Q1 2024, an estimated $972K.
  • Moore Capital Management first reported a position in Biohaven in Q2 2023 and held it in 2 quarters.
  • Moore Capital Management's Biohaven position peaked at $2.39M in Q2 2023.
  • 243 funds tracked by Wall St. Rank held Biohaven as of Q1 2024.

Based on Moore Capital Management's 13F filing for Q1 2024, filed 15 May 2024.